Bevacizumab in Combination with Capecitabine plus Irinotecan as First-Line Therapy in Metastatic Colorectal Cancer: A Pooled Analysis of 2 Phase II Trials
Keyword(s):
Phase Ii
◽
2001 ◽
Vol 37
◽
pp. S272
◽